Prestige Consumer Healthcare Inc.
PBHStock
$50.60−35.65%52W
Market Cap$2.28B
P/E12.00x
Div yield—
Beta0.33
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-32.37%
Price vs S&P 500 (4W)1.21%
VGM Score50.84
Market Capitalization$2.28B
P/E Ratio (Annual)12.00x
Earnings Surprise History
Q4 261.23est. 1.40
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.20
4.20
4.00
4.00
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PBHPrestige Consumer Healthcare Inc. | B | C | D | $50.60 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Prestige Consumer Healthcare is a leading pure-play OTC healthcare provider with a portfolio of category-dominant brands including Clear Eyes, Dramamine, Monistat, and Summer's Eve. These brands maintain strong market positions backed by healthcare professional endorsements. The company generates approximately 85% of revenue from North America, with the remainder from Australia, New Zealand, and select Asian markets.